Selected baseline patient characteristics
| Characteristic . | (%) or median (range) . |
|---|---|
| Age, y | 59.5 (37-67) |
| Sex, female | 15 (62.5) |
| Race | |
| White | 2 (8.3) |
| Mixed | 13 (54.2) |
| Black | 9 (37.5) |
| Hemoglobin, g/dL | 9.8 (6.0-13.8) |
| Platelets, ×103/μL | 210 (97-309) |
| Albumin, g/dL | 4.0 (2.2-4.7) |
| Lactic dehydrogenase, U/L | 205.5 (108-621) |
| Ionized calcium, mg/dL | 1.3 (1.2-1.5) |
| β-2-microglobulin, mg/L | 4.0 (1.8-47.0) |
| International Staging System | |
| I | 11 (45.8) |
| II | 7 (29.2) |
| III | 6 (25.0) |
| Revised International Staging System∗ | |
| I | 6 (28.6) |
| II | 12 (57.1) |
| III | 3 (14.3) |
| Monoclonal pattern | |
| IgG | 15 (62.5) |
| IgA | 4 (16.7) |
| Light-chain only | 5 (20.8) |
| Cytogenetics, high risk† | 7 (35.0)∗ |
| Characteristic . | (%) or median (range) . |
|---|---|
| Age, y | 59.5 (37-67) |
| Sex, female | 15 (62.5) |
| Race | |
| White | 2 (8.3) |
| Mixed | 13 (54.2) |
| Black | 9 (37.5) |
| Hemoglobin, g/dL | 9.8 (6.0-13.8) |
| Platelets, ×103/μL | 210 (97-309) |
| Albumin, g/dL | 4.0 (2.2-4.7) |
| Lactic dehydrogenase, U/L | 205.5 (108-621) |
| Ionized calcium, mg/dL | 1.3 (1.2-1.5) |
| β-2-microglobulin, mg/L | 4.0 (1.8-47.0) |
| International Staging System | |
| I | 11 (45.8) |
| II | 7 (29.2) |
| III | 6 (25.0) |
| Revised International Staging System∗ | |
| I | 6 (28.6) |
| II | 12 (57.1) |
| III | 3 (14.3) |
| Monoclonal pattern | |
| IgG | 15 (62.5) |
| IgA | 4 (16.7) |
| Light-chain only | 5 (20.8) |
| Cytogenetics, high risk† | 7 (35.0)∗ |